New European, American and International guidelines for hypertension management: agreement and disagreement

Expert Rev Cardiovasc Ther. 2004 May;2(3):359-68. doi: 10.1586/14779072.2.3.359.

Abstract

Hypertension is a leading cause of morbidity and mortality worldwide and its control rates remain poor. In 2003, several official organizations presented new guidelines for hypertension management. These guidelines were developed using an evidence-based interpretation of the available information. Recommendations on hypertension prevention, diagnosis, patients' evaluation, decision to treat, antihypertensive drug selection and goals of treatment are included. There is considerable agreement among the new guidelines and only a few points of disagreement, that are of minor significance. Emphasis has been placed on the simplicity of recommendations in order for them to be easily applied by primary care physicians. This review focuses on the key messages of the 2003 guidelines and the areas of agreement and disagreement among them.

Publication types

  • Guideline
  • Practice Guideline
  • Review

MeSH terms

  • Antihypertensive Agents / standards
  • Antihypertensive Agents / therapeutic use
  • Blood Pressure / drug effects
  • Disease Management
  • Europe
  • Humans
  • Hypertension / classification
  • Hypertension / diagnosis
  • Hypertension / drug therapy*
  • Hypertension / physiopathology
  • United States

Substances

  • Antihypertensive Agents